Latest StudyGondim, M.V.P., Sherrill-Mix, S., Bibollet-Ruche, F., Russell, R.M., Trimboli, S., Smith A.G., Li, Y., Liu, W., Avitto, A.N., DeVoto, J., Connell, J., Fenton-May, A.E., Pelligrino, P., Williams, I., Papasavvas, E., Lorenzi, J.C.C., Salantes, D.B., Mampe, F., Monroy, M.A., Cohen, Y.Z., Heath, S., Saag, M.S., Montaner, L.J., Collman, R.G., Siliciano, J., Siliciano, R.F., Plenderleith, L., Sharp, P.M., Caskey, M., Nussenzweig, M.C., Shaw, G.M., Borrow, P., Bar, K.J., Hahn, B.H. Heightened resistance to type 1 interferons characterizes HIV-1 at transmission and following analytical treatment interruption. Science Translational Medicine. 2021 Jan 13; 13(576): eabd8179. Doi: 10.1126/scitranslmed.abd8179 |
Schonhofer, C., Yi, J., Sciorillo, A., Andrae-Marobela, K., Cochrane, A., Harris, M., Brumme, Z.L., Brockman, M.A., Mounzer, K., Hart, C., Yuan, Z., Montaner, L.J., Tietjen, I. Flavonoid-based inhibition of cyclin-dependent kinase-9 without concomitant inhibition of histone deacetylases durably reinforces HIV latency. Biochem. Pharmacol. 2021 April. Doi: 10.16/j.bcp.2021.114462. Online ahead of print.
Simonetti, F.R., Zhang, H., Soroosh, G.P., Duan, J., Rhodehouse, K., Hill, A.L., Beg, S.A., McCormick, K., Raymond, H.E., Nobles, C.L., Everett, J.K., Kwon, K.J., White, J.A., Lai, J., Margolick, J.B., Hoh, R., Deeks, S.G., Bushman, F.D., Siliciano, J.D., Siliciano, R.F. Antigen-driven clonal selection shapes the persistence of HIV-1-infected CD4+ T cells in vivo. J. Clin. Invest. 2021 Feb 1; 131(3): e1345254. Doi: 10.1172/JCI145254.
Papasavvas, E., Azzoni, L., Paggliuzza, A., Abdel-Mohsen, M., Ross, B.N., Fair, M., Howell, B., Hazuda,D., Chomont, N., Li, Q., Mounzer, K., Kostman, J.R., Tebas, P., Montaner L.J. Safety, immune and anti-viral effects of pegylated interferon alpha 2b administration in ART-suppressed individuals: Results of pilot clinical trial. AIDS Res Hum Retroviruses. 2021 Jan 29. Doi: 10.1089/AID.2020.0243. Online ahead of print.
Hayn, M., Blötz, A., Rodriguez, A., Vidal, S., Preising, N., Ständker, L., Wiese, S., Stürzel, C.M., Harms, M., Gross, R., Jung, C., Kiene, M., Jacob, T., Pöhlmann, S., Forssmann, W-G., Münnch, J., Sparrer, K.M.J., Seuwen, K., Hahn, B.H., Kirchhoff, F. Natural cystatin C fragments inhibit GPR15-mediated HIV and SIV infection without interfering with GPR15L signaling. PNAS. 2021 Jan 19. 118(3): e2023776118. Doi: 10.1073/pnas.20237761118
Ziani, W., Shao, J., Wang, X, Russell-Lodrigue, K., Liu, Y,-Z., Montaner, L.J., Veazey, R., Xu, H. Increased proviral DNA in circulating cells correlates with plasma viral rebound in SIV-infected rhesus macaques after antiretroviral therapy interruption. J. Virology. 2021 Jan 6. Doi: 1010.1128/JVI.02064-20. Online ahead of print.
Gaebler, C., Falcinelli, S.D., Stoffel, E., Read, J., Murtagh, R., Oliveira, T.Y., Ramos, V., Lorrenzi, J.C.C., Kirchherr, J., James, K.S., Allard, B., Baker, C., Kuruc, J.D., Caskey, M., Archin, N.M., Siliciano, R.F., Margolis, D.M., Nussenzweig, M.C. Sequence evaluation and comparative analysis of nnovel assays for intanct proviral HIV-1 DNA. J Virol. 2020 Dec 23. JVI.01986-20. Doi: 10.1128/JVI.01986-20.
Buggert, M., Vella, L.A., Nguyen, S., Wu, V.H., Chen, Z., Sekine, T., Perez-Potti. A., Maldini, C.R., Manne, S., Darko, S., Ransier, A., Kuri-Cervantes, L., Japp. A.S., Brody, I.B., Ivarsson, M.A., Gorin, J-B., Rivera-Ballesteros, O., Hertwig, L., Antel. J.P., Johnson, M.E., Okoye, A., Picker, L., Vahedi, G., Sparrelid, E., Llewellyn-Lacey, S., Gostick, E., Sandberg, J.K., Björkström, N., Bar-Or, A., Dori, Y., Naji, A., Canaday, D.H., Laufer, T.M., Wells, A.D., Price, D.A., Frank, I., Douek, D.C., Wherry, E.J., Itkin, M.G., Betts, M.R. The Identity of Human Tissue-Emigrant CD8 + T Cells. Cell. 2020 Dec 23; 183(7):1946-1961.e15. doi: 10.1016/j.cell.2020.11.019. Epub 2020
Bertagnolli, L.N., Varriale, J., Lynn, K., Mounzer, K.M., Frank, I., Tebas, P., Montaner, L.J., Siliciano, R.F., Siliciano, J.D. Autologous IgG antibodies block outgrowth from a major portion of viruses in the latent reservoir for HIV-1. PNAS. 2020 Dec 15; 117(50): 32066-32077. Doi: 10.1073/pnas.2020617117.
Tomescu, C., Colon, K., Smith, P., Taylor, M., Azzoni, L., Metzger, D.S., Montaner, L.J. 2020. Persons who inject drugs retain a functional innate and adaptive immune recall response despite prolonged opioid use. Journal of Leukocyte Biology. J. Leukoc Biol. 2020 Dec 2. Doi: 10.1002/JLB.5A0920-604R. Online ahead of print.
Volbrecht, T., Angerstein, A.O., Menke, B., Kumar, N.M., de Oliveira, M.F., Richman, D.D., Guatelli, J.C. Inconsistent reversal of HIV-2 latency ex vivo by antigens of HIV-1, CMV, and other infectious agents. Retrovirology. 2020 Nov 23; 17:36. Doi: 10.1186/s12977-020-00546-x.
Bakkour, S., Deng, X., Bacchetti, P., Grebe, E., Montalvo, L., Worlock, A., Stone, M., Deeks, S.G., Richman, D.D., Busch, M. Replicate aptima assay for quantifying residual plasma viremia inn individuals on antiretroviral therapy. J. Clin. Microbiol. 2020 Nov 18. 58(12): e01400-20. Doi: 10.1128/JCM.01400-20.
Maldini, C.R., Claiborne, D.T., Okawa, K., Chen, T., Dopkin, D.L., Shan, X., Power, K.A., Trifonova, R.T., Krupp, K., Phelps, M., Vrbanac, V.D., Tanno, S., Bateson, T., Leslie, G.J., Hoxie, J.A., Boutwell, C.L., Riley, J.L., Allen, T.M. Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo. Nat. Med. 2020 Nov; 26(11): 1776-1787. Doi: 10.1038/s41591-020-1039.5
Dubé, K., Willinberg, L., Dee, L., Sylla, L., Taylor, J., Roebuck, C., Palm, D., Campbell, D., Newton, L., Patel, H., Perry, K.E., Kanazawa, J., Gerrard, J., Brown, B., Saberi, P., Sauceda, J.A., Peluso, M.J. Re-examining the HIV ‘functional cure’ oxymoron: Time for precise terminology? J. Virus Erad. 2020 Oct 14; 6(4): 100017. Doi: 10.1016/j.jve.2020.100017
Richard, K., Schonhofer, C., Giron, L.B., Rivera-Ortiz, J., Read, S., Kannan, T., Kinloch, N.N., Shahid, A., Feilcke, R., Wappler, S., Imming, P., Harris, M., Brumme, Z.L., Brockman, M.A., Mounzer, K., Kossenkov, A., Abdel-Mohsen, M., Andrae-Marobela, K., Montaner, L.J., Tietjen, I. The African national product knipholone anthrone and its analogue anthralin (dithranol) enhance HIV-1 latency reversal. Journal of Biological Chemistry. 2020 Oct 9; 295(41): 14084-14099. Doi: 10.1074/jbc.RA120.013031.
Yeh, Y-H.J., Jenike, K.M., Calvi, R.M., Chiarella, J., Hoh, R., Deeks, S.G., Ho, Y-C. Filgotinib suppresses HIV-1-drivenn gene transcription by inhibiting HIV-1 splicing and T cell activation. J. Clin. Invest. 2020 Sept 1; 130(9): 4969-4984. Doi: 10.1172/JCI137371
Dubé, K., Perry, K.E., Mathur, K., Lo, M., Jaadi, S.S,, Patel, H., Concha-Garcia, S., Taylor, J., Kaytes, A., Dee, L., Campbell, D., Kanazaw, J., Smith, D., Gianella, S., Auerbach, J.D., Saberi, P., Sauceda, J.A. Altruism: Scoping review of the literature and future directions for HIV cure-related research. J. Virus Erad. 2020 Aug 25; 6(4): 100008. Doi: 10.1016/j.jve.2020.100008.
Abdel-Mohsen, M., Richman, D., Siliciano, R.F., Nussenzweig, M.C., Howell, B., Martinez-Picado, J., Chomont, N., Bar, K.J., Yu, X.G., Lichterfeld, M., Alcami, J., Hazuda, D., Bushman, F., Siliciano, J., Betts, M.R., Spivak, A.M., Planelles, V., Hahn, B.H., Smith, D.M., Ho, Y.-C., Buzon, M.J., Gaebler, C., Paiardini, M., Li, Q., Estes, J.D., Hope, T.J., Kostman, J., Mounzer, K., Caskey, M., Fox, L., Frank, I., Riley, J.L., Tebas, P., Montaner, L.J. for The BEAT-HIV Delaney Collaboratory to Cure HIV-1 infection. Recommendations for measuring HIV reservoir size in cure-directed clinical trials. Nature Medicine. 2020. 26(9): 1339-1350. doi: 10.1038/s41591-020-1022-1.
Jiang, C., Lian, X., Gao, C., Sun, X., Einkauf, K.B., Chevalier, J.M., Chen, S.M.Y., Hua, S., Rhee, B., Chang, K., Blackmer, J.E., Osborn, M., Peluso, M.J., Hoh, R., Somsouk, M., Milush, J., Bertagnolli, L.M., Sweet, S.E., Varriale, J.A., Burbelo, P.D., Chun, T.-W., Laird, G.M., Serrao, E., Engelman, A.N., Carrington, M., Siliciano, R.F., Siliciano, J.M., Deeks, S.G., Walker, B.D., Lichterfeld, M., Yu, X.G. Distinct viral reservoirs in individuals with spontaneous control of HIV-1. Nature. 2020. 585(7824): 261-267. doi: 10.1038/s41586-020-2651-8
Simonetti, F.R., White, J.A., Tumiotto, C., Ritter, K.D., Cai, M., Gandhi, R.T., Deeks, S.G., Howell, B.J., Montaner, L.J., Blankson, J.N., Martin, A., Laird, G.M., Siliciano, R.F., Mellors, J.W., Siliciano, J.D. Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA. Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18692-18700. doi: 10.1073/pnas.2006816117.
Colomb, F., Giron, L.B., Kuri-Cervantes, L., Adeniji, O.S., Ma, T., Dweep, H., Battivelli, E., Verdin, E., Palmer, C.S., Tateno, H., Kossenkov, A.V., Roan, N.R., Betts, M.R., Abdel-Mohsen, M. Sialyl-LewisX Glycoantigen Is Enriched on Cells with Persistent HIV Transcription during Therapy. Cell Rep. 2020 Aug 4;32(5):107991. doi: 10.1016/j.celrep.2020.107991.
Maldini, C.R., Love, A.C., Tosh, K.W., Chan, L.L., Gayout, K., Smith, T., Riley, J.L. Characterization of CAR T cell expansion and cytotoxic potential during Ex Vivo manufacturing using image-based cytometry. J Immunol Methods. 2020 Aug 1:112830. doi: 10.1016/j.jim.2020.112830.
Giron, L.B., Azzoni, L., Yin, X., Lynn, K.M., Ross, B.N., Fair, M., Damra, M., Sciorillo, A.C., Liu, Q., Jacobson, J.M., Mounzer, K., Kostman, J.R., Abdel-Mohsen, M., Montaner, L.J., Papasavvas, E. Hepatitis C virus modulates IgG glycosylation in HIV co-infected antiretroviral therapy suppressed individuals. AIDS. 2020 Aug 1;34(10):1461-1466. doi: 10.1097/QAD.0000000000002558.
Sorensen, E.S., Macedo, A.B., Resop, R.S., Howard, J.N., Nell, R., Sarabia, I., Newman, D., Ren, Y., Jones, R.B., Planelles, V., Spivak, A.M., Bosque, A. Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing Agents. Antimicrob Agents Chemother. 2020 Jul 22;64(8):e00888-20. doi: 10.1128/AAC.00888-20.
Hopfensperger, K., Richard, J., Stürzel, C.M., Bibollet-Ruche, F., Apps, R., Leoz, M., Plantier, J.C., Hahn, B.H., Finzi, A., Kirchhoff, F., Sauter, D. Convergent Evolution of HLA-C Downmodulation in HIV-1 and HIV-2. mBio. 2020 Jul 14;11(4):e00782-20. doi: 10.1128/mBio.00782-20.
Rust, B.J., Kean, L.S., Colonna, L., Brandenstein, K., Poole, N.H., Obenza, W., Enstrom, M.R., Maldini, C.R., Ellis, G.I., Fennessey, C.M., Huang, M.L., Keele, B.F., Jerome, K., Riley, J.L., Kiem, H.P., Peterson, C.W. Robust Expansion of HIV CAR T Cells Following Antigen Boosting in ART-Suppressed Nonhuman Primates. Blood. 2020 Jul 2:blood.2020006372. doi: 10.1182/blood.2020006372.
Maldini, C.R., Gayout, K., Leibman, R.S., Dopkin, D.L., Mills, J.P., Shan, X., Glover, J.A., Riley, J.L. HIV-Resistant and HIV-Specific CAR-Modified CD4+ T Cells Mitigate HIV Disease Progression and Confer CD4+ T Cell Help In Vivo. Mol Ther. 2020 Jul 8;28(7):1585-1599. doi: 10.1016/j.ymthe.2020.05.012.
Timmons, A., Fray, E., Kumar, M., Wu, F., Dai, W., Bullen, C.K., Kim, P., Hetzel, C., Yang, C., Beg, S., Lai, J., Pomerantz, J.L., Yukl, S.A., Siliciano, J.D., Siliciano, R.F. HSF1 inhibition attenuates HIV-1 latency reversal mediated by several candidate LRAs In Vitro and Ex Vivo. Proc Natl Acad Sci U S A. 2020 Jul 7;117(27):15763-15771. doi: 10.1073/pnas.1916290117.
Mendoza, P., Jackson, J.R., Oliveira, T.Y., Gaebler, C., Ramos, V., Caskey, M., Jankovic, M., Nussenzweig, M.C., Cohn, L.B.. Antigen-responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir. J Exp Med. 2020 Jul 6;217(7):e20200051. doi: 10.1084/jem.20200051.
Antar, A.A., Jenike, K.M., Jang, S., Rigau, D.N., Reeves, D.B., Hoh, R., Krone, M.R., Keruly, J.C., Moore, R.D., Schiffer, J.T., Nonyane, B.A., Hecht, F.M., Deeks, S.G., Siliciano, J.D., Ho, Y.C., Siliciano, R.F. Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy. J Clin Invest. 2020 Jul 1;130(7):3543-3559. doi: 10.1172/JCI135953.
Papasavvas, E., Azzoni, L, Ross, B.N., Fair, M, Yuan, Z., Gyampoh, K., Sciorillo, A.C., Paggliuzza, A., Lada, S., Wu, Gioxin, G., Goh, S.L., Banck-Teets, C., Holder, D.J., Zuck, P.D., Damra, M., Lynn, K.M., Tebas, P., Mounzer, K., Kostman, J.R., Abdel-Mohsen, M., Richman, D., Chomont, N., Howell, B.J., Montaner, L.J. Intact HIV reservoir estimated by the intact proviral DNA assay correlates with levels of total and integrated DNA in the blood during suppressive antiretroviral therapy. Clin. Infect. Dis. 2021 Feb 1; 72(3): 495-498.
Liu, R., Yeh, Y.J., Varabyou, A., Collora, J.A., Sherrill-Mix, S., Talbot, C.C. Jr., Mehta, S., Albrecht, K., Hao, H., Zhang, H., Pollack, R.A., Beg, S.A., Calvi, R.M., Hu, J., Durand, C.M., Ambinder, R.F., Hoh, R., Deeks, S.G., Chiarella J, Spudich S, Douek DC, Bushman FD, Pertea M, Ho YC. Single-cell transcriptional landscapes reveal HIV-1-driven aberrant host gene transcription as a potential therapeutic target. Sci Transl Med. 2020 May 13;12(543):eaaz0802. doi: 10.1126/scitranslmed.aaz0802.
Dubé, K., Dee, L. Willingness to risk death endpoint in HIV cure-related research with otherwise healthy volunteers is misleading. J Virus Erad. 2020 Apr 30;6(2):81-84.
Dubé, K., Hosey, L., Starr, K., Barr, L., Evans, D., Hoffman, E., Campbell, D.M., Simoni, J., Sugarman, J., Sauceda, J., Brown, B., Diepstra, K.L., Godfrey, C., Kuritzkes, D.R., Wohl, D.A., Gandhi, R., Scully, E. Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366. AIDS Res Hum Retroviruses. 2020 Apr;36(4):268-282. doi: 10.1089/AID.2019.0284.
Dubé, K., Eskaf, S., Evans, D., Sauceda, J., Saberi, P., Brown, B., Averitt, D., Martel, K., Meija, M., Campbell, D., Barr, L., Kanazawa, J., Perry, K., Patel, H., Luter, S., Poteat, T., Auerbach, J.D., Wohl, D.A. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2020 Apr;36(4):324-348. doi: 10.1089/AID.2019.0175.
Giron, L.B., Papasavvas, E., Azzoni, L., Yin, X., Anzurez, A., Damra, M., Mounzer, K., Kostman, J.R., Sanne, I., Firnhaber, C.S., Tateno, H., Liu, Q., Montaner, L.J., Abdel-Mohsen, M. Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpoint. AIDS. 2020 Apr 1;34(5):681-686. doi: 10.1097/QAD.0000000000002476.
Bauer, A.M., Ziani, W., Lindemuth, E., Kuri-Cervantes, L., Li, H., Lee, F.H., Watkins, M., Ding, W., Xu, H., Veazey, R., Bar, K.J. Novel Transmitted/Founder Simian-Human Immunodeficiency Viruses for Human Immunodeficiency Virus Latency and Cure Research. J Virol. 2020 Mar 31;94(8):e01659-19. doi: 10.1128/JVI.01659-19.
Stone, M., Rosenbloom, D., Bacchetti, P., Deng, X., Dimapasoc, M., Keating, S., Bakkour, S., Richman, D., Mellors, J., Deeks, S., Lai, J., Beg, S., Siliciano, J., Pagliuzza, A., Chomont, N., Lackman-Smith, C., Ptak, R.G., Busch, M.P.; Reservoir Assay Validation and Evaluation Network (RAVEN) Study Group. Assessing suitability of next-generation viral outgrowth assays as proxies for classic QVOA to measure HIV-1 latent reservoir size. J Infect Dis. 2020 Mar 9:jiaa089. doi: 10.1093/infdis/jiaa089.
Giron, L.B., Tanes, C.E., Schleimann, M.H., Engen, P.A., Mattei, L.M., Anzurez, A., Damra, M., Zhang, H., Bittinger, K., Bushman, F., Kossenkov, A., Denton, P.W., Tateno, H., Keshavarzian, A., Landay, A.L., Abdel-Mohsen, M. Sialylation and fucosylation modulate inflammasome-activating eIF2 Signaling and microbial translocation during HIV infection. Mucosal Immunol. 2020 Mar 9. doi: 10.1038/s41385-020-0279-5.
Cai, Y., Watkins, M.A., Xue, F., Ai, Y., Cheng, H., Midkiff, C.C., Wang, X., Alvarez, X., Poli, A.N.R., Salvino, J.M., Veazey, R.S., Montaner, L.J. BCL6 BTB-specific inhibition via FX1 treatment reduces Tfh cells and reverses lymphoid follicle hyperplasia in Indian rhesus macaque (Macaca mulatta). J Med Primatol. 2020 Feb;49(1):26-33. doi: 10.1111/jmp.12438.
Peluso, M.J., Bacchetti, P., Ritter, K.D., Beg, S., Lai, J., Martin, J.N., Hunt, P.W., Henrich, T.J., Siliciano, J.D., Siliciano, R.F., Laird, G.M., Deeks, S.G. Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy. JCI Insight. 2020 Feb 27;5(4):e132997. doi: 10.1172/jci.insight.132997.
Niessl, J., Baxter, A.E., Mendoza, P., Jankovic, M., Cohen, Y.Z., Butler, A.L., Lu, C.L., Dubé, M., Shimeliovich, I., Gruell, H., Klein, F., Caskey, M., Nussenzweig, M.C., Kaufmann, D.E.. Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity. Nat Med. 2020 Feb;26(2):222-227. doi: 10.1038/s41591-019-0747-1.
Caskey, M. Broadly neutralizing antibodies for the treatment and prevention of HIV infection. Curr Opin HIV AIDS. 2020 Jan;15(1):49-55. doi: 10.1097/COH.0000000000000600.
Kmiec, D., Nchioua, R., Sherrill-Mix, S., Stürzel, C.M., Heusinger, E., Braun, E., Gondim, M.V.P., Hotter, D., Sparrer, K.M.J., Hahn, B.H., Sauter, D., Kirchhoff, F. CpG Frequency in the 5′ Third of the env Gene Determines Sensitivity of Primary HIV-1 Strains to the Zinc-Finger Antiviral Protein. mBio. 2020 Jan 14;11(1):e02903-19. doi: 10.1128/mBio.02903-19.
Liu, R., Simonetti, F.R., Ho, Y.C. The forces driving clonal expansion of the HIV-1 latent reservoir.Virol J. 2020 Jan 7;17(1):4. doi: 10.1186/s12985-019-1276-8.
Freshwater, W. From Early AIDS Vaccine to HIV Cure Research with Analytical Treatment Interruption Trials: A Study Participant Testimonial. Journal of Virus Eradication . 2019.
Nguyen, S., Deleage, C., Darko, S., Ransier, A., Truong, D.P., Agarwal, D., Japp, A.S., Wu, V.H., Kuri-Cervantes, L., Abdel-Mohsen, M., Del Rio Estrada, P.M., Ablanedo-Terrazas, Y., Gostick, E., Hoxie, J.A., Zhang, N.R., Naji, A., Reyes-Terán, G., Estes, J.D., Price, D.A., Douek, D.C., Deeks, S.G., Buggert, M., Betts, M.R. Elite control of HIV is associated with distinct functional and transcriptional signatures in lymphoid tissue CD8+ T cells. Sci Transl Med. 2019 Dec 18;11(523):eaax4077. doi: 10.1126/scitranslmed.aax4077.
Rodríguez-Mora, S., Spivak, A.M., Szaniawski, M.A., López-Huertas, M.R., Alcamí, J., Planelles, V., Coiras, M. Tyrosine Kinase Inhibition: a New Perspective in the Fight against HIV. Curr HIV/AIDS Rep. 2019 Oct;16(5):414-422. doi: 10.1007/s11904-019-00462-5.
Dubé, K., Auerbach, J.D., Stirratt, M.J., Gaist, P. Applying the Behavioural and Social Sciences Research (BSSR) Functional Framework to HIV Cure Research. J Int AIDS Soc. 2019 Oct;22(10):e25404. doi: 10.1002/jia2.25404.
Read, D.F., Atindaana, E., Pyaram, K., Yang, F., Emery, S., Cheong, A., Nakama, K.R., Burnett, C., Larragoite, E.T., Battivelli, E., Verdin, E., Planelles, V., Chang, C.H., Telesnitsky, A., Kidd, J.M. Stable integrant-specific differences in bimodal HIV-1 expression patterns revealed by high-throughput analysis. PLoS Pathog. 2019 Oct 4;15(10):e1007903. doi: 10.1371/journal.ppat.1007903
Thans, T.V.S., Akko, J.I., Niehrs, A., Garcia-Beltran, W.F., Richert, L., Stürzel, C.M., Ford, C.T., Li, H., Ochsenbauer, C., Kappes, J.C., Hahn, B.H., Kirchhoff, F., Martrus, G., Sauter, D., Altfeld, M., Hölzemer, A. Primary HIV-1 strains use Nef to downmodulate HLA-E surface expression. J Virol. 2019 Sep 30;93(20). pii: e00719-19. doi: 10.1128/JVI.00719-19.
Kim, G.B., Hege, K., Riley, J.L. CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV. Front Immunol. 2019 Sep 27;10:2310. doi: 10.3389/fimmu.2019.02310.
Goswami, R., Nelson, A.N., Tu, J.J., Dennis, M., Feng, L., Kumar, A., Mangold, J., Mangan, R.J., Mattingly, C., Curtis, A.D. 2nd, Obregon-Perko, V., Mavigner, M., Pollara, J., Shaw, G.M., Bar, K.J., Chahroudi, A., De Paris, K., Chan, C., Van Rompay, K.K.A., Permar, S.R. Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque Model. mBio. 2019 Sep 5;10(5):e01971-19. doi: 10.1128/mBio.01971-19.
Bar, K.J., Coronado, E., Hensley-McBain, T., O’Connor, M.A., Osborn, J.M., Miller, C., Gott, T.M., Wangari, S., Iwayama, N., Ahrens, C.Y., Smedley, J., Moats, C., Lynch, R.M., Haddad, E.K., Haigwood, N.L., Fuller, D.H., Shaw, G.M., Klatt, N.R., Manuzak, J.A. 2019. SHIV.CH505 infection of rhesus macaques results in persistent viral replication and induces intestinal immunopathology. J Virol. 2019 Aug 28;93(18). pii: e00372-19. doi: 10.1128/JVI.00372-19.
Gaebler, C., Lorenzi, J.C.C., Oliveira, T.Y., Nogueira, L., Ramos, V., Lu, C.L., Pai, J.A., Mendoza, P., Jankovic, M., Caskey, M., Nussenzweig, M.C. Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir. J Exp Med. 2019 Jul 26. pii: jem.20190896. doi: 10.1084/jem.20190896.
Papasavvas, E., Azzoni, L, Montaner, L.J., et al. NK response correlates with HIV decrease in pegylated-IFN-α2a-treated ART-suppressed subjects. J Immunology. Aug 1;203(3):705-717. doi: 10.4049/jimmunol.1801511. Epub 2019 Jun 28.
Nelson, A.N., Goswami, R., Dennis, M., Tu, J., Mangan, R.J., Saha, P.T., Cain, D.W., Curtis, A.D., Shen. X., Shaw, G.M., Bar, K., Hudgens, M., Pollara, J., De., Paris, K., Van, Rompay, K.A., Permar, S.R. Simian-Human Immunodeficiency Virus SHIV.CH505-Infected Infant and Adult Rhesus Macaques Exhibit Similar Env-Specific Antibody Kinetics, despite Distinct T-Follicular Helper and Germinal Center B Cell Landscapes. J Virol. 2019 Jul 17;93(15). pii: e00168-19. doi: 10.1128/JVI.00168-19. Print 2019 Aug 1.
Bender, A.M., Simonetti, F.R., Kumar, M.R., Fray, E.J., Bruner, K.M., Timmons, A.E., Tai, K.Y., Jenike, K.M., Antar, A.A.R., Liu, P.T., Ho, Y.C., Raugi, D.N., Seydi, M., Gottlieb, G.S., Okoye, A.A., Del Prete, G.Q., Picker, L.J., Mankowski, J.L., Lifson, J.D., Siliciano, J.D., Laird, G.M., Barouch, D.H., Clements, J.E., Siliciano, R.F. The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections. Cell Host Microbe. 2019 Jul 10;26(1):73-85.e4. doi: 10.1016/j.chom.2019.06.005.
Prévost, J., Pickering, S., Mumby, M.J., Medjahed, H., Gendron-Lepage, G., Delgado, G.G., Dirk, B.S., Dikeakos, J.D., Stürzel, C.M., Sauter, D., Kirchhoff, F., Bibollet-Ruche, F., Hahn, B.H., Dubé. M., Kaufmann, D.E., Neil, S.J.D., Finzi, A., Richard, J. Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses. MBio. 2019 Jun 18;10(3). pii: e01113-19. doi: 10.1128/mBio.01113-19.
Hotter, D., Bosso, M., Jønsson, K.L., Krapp, C., Stürzel, C.M., Das, A., Littwitz-Salomon, E., Berkhout, B., Russ, A., Wittmann, S., Gramberg, T., Zheng, Y., Martins, L.J., Planelles, V., Jakobsen, M.R., Hahn, B.H., Dittmer, U., Sauter, D., Kirchhoff, F. IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency Reactivation. Cell Host Microbe. 2019 Jun 12;25(6):858-872.e13. doi: 10.1016/j.chom.2019.05.002. Epub 2019 Jun 4.
Cavazzana, M., Bushman, F.D., Miccio, A., André-Schmutz, I., Six, E. 2019. Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges. Nat Rev Drug Discov. 2019 Jun;18(6):447-462. doi: 10.1038/s41573-019-0020-9.
Julg, B., Dee, L., Ananworanich, J., Barouch, D.H., Bar, K.,Caskey, M., Colby, D.J., Dawson, L., Dong, K.L., Dubé, K.,Eron, J., Frater, J., Gandhi, R.T., Geleziunas, R., Goulder, P., Hanna, G.J., Jefferys, R., Johnston, R., Kuritzkes, D., Li, J.Z., Likhitwonnawut, U., van Lunzen, J., Martinez-Picado, J., Miller, V., Montaner, L.J., Nixon, D.F., Palm, D., Pantaleo, G., Peay, H., Persaud, D., Salzwedel, J., Salzwedel, K., Schacker, T., Sheikh, V., Søgaard, O.S., Spudich, S., Stephenson, K., Sugarman, J., Taylor, J., Tebas, P.,Tiemessen, C.T., Tressler, R., Weiss, C.D., Zheng, L., Robb, M.L., Michael, N.L., Mellors, J.W., Deeks, S.G., Walker, B.D. Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting. Lancet HIV. 2019 Apr;6(4):e259-e268. doi: 10.1016/S2352-3018(19)30052-9. Epub 2019 Mar 15.
Rosenbloom, D.I.S., Bacchetti, P., Stone, M., Deng, X., Bosch, R.J., Richman, D.D., Siliciano, J.D., Mellors, J.W., Deeks, S.G., Ptak, R.G., Hoh, R., Keating, S.M., Dimapasoc, M., Massanella, M., Lai, J., Sobolewski, M.D., Kulpa, D.A., Busch, M.P.; Reservoir Assay Validation and Evaluation Network (RAVEN) Study Group. Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size. PLoS Comput Biol. 2019 Apr 12;15(4):e1006849. doi: 10.1371/journal.pcbi.1006849. eCollection 2019 Apr.
Caskey, M, Klein, F., Nussenzweig, M.C. Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic. Nat Med. 2019 Apr;25(4):547-553. doi: 10.1038/s41591-019-0412-8. Epub 2019 Apr 1.
Colomb. F., Giron, L.B., Trbojevic-Akmacic, I., Lauc, G., Abdel-Mohsen, M. Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis. Curr HIV/AIDS Rep. 2019 Apr;16(2):151-168. doi: 10.1007/s11904-019-00433-w.
Buggert. M., Japp, A.S., Betts, M.R. Everything in its right place: resident memory CD8+ T cell immunosurveillance of HIV infection. Curr Opin HIV AIDS. 2019 Mar;14(2):93-99. doi: 10.1097/COH.0000000000000523.
Colomb, F., Giron, L.B., Premeaux, T.A., Mitchell, B.I., Niki, T., Papasavvas, E., Montaner, L,J., Ndhlovu, L.C., Abdel-Mohsen, M. Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK Signaling. Front Immunol. 2019 Feb 20;10:267. doi: 10.3389/fimmu.2019.00267. eCollection 2019.
Bibollet-Ruche, F., Russell, R.M., Liu, W., Stewart-Jones, G.B.E., Sherrill-Mix, S., Li, Y., Learn, G.H., Smith, A.G., Gondim, M.V.P., Plenderleith, L.J., Decker, J.M., Easlick, J.L., Wetzel, K.S., Collman, R.G., Ding, S., Finzi, A., Ayouba, A., Peeters, M., Leendertz, F.H., van Schijndel, J., Goedmakers, A., Ton, E., Boesch, C., Kuehl, H., Arandjelovic, M., Dieguez, P., Murai, M., Colin, C., Koops, K., Speede, S., Gonder, M.K., Muller, M.N., Sanz, C.M., Morgan, D.B., Atencia, R., Cox, D., Piel, A.K., Stewart, F.A., Ndjango, J.N., Mjungu, D., Lonsdorf, E.V., Pusey, A.E., Kwong, P.D., Sharp, P.M., Shaw, G.M., Hahn, B.H. CD4 receptor diversity in chimpanzees protects against SIV infection. Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):3229-3238. doi: 10.1073/pnas.1821197116. Epub 2019 Feb 4.
Richman, D.D., Huang, K., Lada, S.M., Sun, X., Jain, S., Massanella, M., Menke, B. Replication competence of virions induced from CD4+ lymphocytes latently infected with HIV. Retrovirology. 2019 Feb 15;16(1):4. doi: 10.1186/s12977-019-0466-1.
Szaniawski, M.A., Spivak, A.M., Bosque, A., Planelles, V. Sex Influences SAMHD1 Activity and Susceptibility to Human Immunodeficiency Virus-1 in Primary Human Macrophages. J Infect Dis. 2019 Feb 15;219(5):777-785. doi: 10.1093/infdis/jiy583.
Bruner, K.M., Wang, Z., Simonetti, F.R., Bender, A.M., Kwon, K.J., Sengupta, S., Fray, E.J., Beg, S.A., Antar, A,A.R., Jenike, K.M., Bertagnolli, L.N., Capoferri, A.A., Kufera, J.T., Timmons, A., Nobles, C., Gregg, J., Wada, N., Ho, Y.C., Zhang, H., Margolick, J.B., Blankson, J.N., Deeks, S.G., Bushman, F.D., Siliciano, J.D., Laird, G.M., Siliciano, R.F. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses. Nature. 2019 Feb;566(7742):120-125. doi: 10.1038/s41586-019-0898-8.
Siddiqui, S., Perez, S., Gao, Y., Doyle-Meyers, L., Foley, B.T., Li, Q., Ling, B. Persistent Viral Reservoirs in Lymphoid Tissues in SIV-Infected Rhesus Macaques of Chinese-Origin on Suppressive Antiretroviral Therapy. Viruses. 2019 Jan 27;11(2). pii: E105. doi: 10.3390/v11020105.
Kwaa AKR, Talana CAG, Blankson JN. “Interferon-α Enhances NK Cell Function and the Suppressive Capacity of HIV-specific CD8+ T Cells“. J Virol. 2019. 93(3), pii: e01541.
Einkauf KB, Lee GQ, Gao C, Sharaf R, Sun X, Hua S, Chen SMY, Jiang C, Lian X, Chowdhury FZ, Rosenberg ES, Chun T-W, Li JZ, Yu XG, Lichterfeld M. “Intact HIV-1 proviruses accumulate at distinct positions during prolonged antiretroviral therapy“. Journal of Clinical Investigation. 2019. 129(3): 988-998.
Lu CL, Pai JA, Nogueira L, Mendoza P, Gruell H, Oliveira TY, Barton J, Lorenzi JCC, Cohen YZ, Cohn LB, Klein F, Caskey M, Nussenzweig MC, Jankovic M. “Relationship between intact HIV-1 proviruses in circulating CD4(+) T cells and rebound viruses emerging during treatment interruption“. Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):E11341-E11348. PMCID: PMC6275529.
Bar-On Y, Gruell H, Schoofs T, Pai JA, Nogueira L, Butler AL, Millard K, Lehmann C, Suárez I, Oliveira TY, Karagounis T, Cohen YZ, Wyen C, Scholten S, Handl L, Belblidia S, Dizon JP, Vehreschild JJ, Witmer-Pack M, Shimeliovich I, Jain K, Fiddike K, Seaton KE, Yates NL, Horowitz J, Gulick RM, Pfeifer N, Tomaras GD, Seaman MS, Fätkenheuer G, Caskey M, Klein F, Nussenzweig MC. “Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals“. Nat Med. 2018 Nov;24(11):1701-1707. PMCID: PMC6221973.
Lada SM, Huang K, VanBelzen DJ, Montaner LJ, O’Doherty U, Richman DD. “Quantitation of Integrated HIV Provirus by Pulsed-Field Gel Electrophoresis and Droplet Digital PCR“. J Clin Microbiol. 2018 Nov 27;56(12). pii: e01158-18. PMCID: PMC6258838.
Colon K, Speicher DW, Smith P, Taylor M, Metzger DS, Montaner LJ, Tomescu C. “S100A14 is Increased in Activated NK cells and Plasma of HIV-Exposed Seronegative People Who inject Drugs and Promotes Monocyte-NK Crosstalk“. JAIDS. 2018. November 5. [Epub ahead of print].
Siliciano JD, Siliciano RF. “Assays to Measure Latency, Reservoirs, and Reactivation“. Top Microbiol Immunol. 2018; 417:23-41. PMID: 29071475.
Maldini CR, Ellis GI, Riley JL. “CAR T cells for infection, autoimmunity and allotransplantation“. Nat Rev Immunol. 2018 Oct;18(10):605-616. PMID: 30046149.
Cai Y, Abdel-Mohsen M, Tomescu C, Xue F, Wu G, Howell BJ, Yong AI, Sun J, Azzoni L, Le Coz C, Romberg N, Montaner LJ. “BCL6 Inhibitor-mediated Downregulation of pSAMHD1 and T Cell Activation Are Negatively Associated with HIV Infection and Reactivation“. Journal of Virology. 2018. October 24. [Epub ahead of print].
Spivak AM, Nell RA, Petersen M, Martins L, Sebahar P, Looper RE, Planelles V. “Synthetic Ingenols Maximize Protein Kinase C-Induced HIV-1 Latency Reversal“. Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01361-18. PMCID: PMC6201092.
Szaniawski MA, Spivak AM, Bosque A, Planelles V. “Sex influences SAMHD1 activity and susceptibility to HIV-1 in primary human macrophages“. J. Inf. Diseases. 2018. PMID 30299483.
Williams B, Boucher C, Bushman F, Carrington-Lawrence S, Collman R, Dandekar S, Dang Q, Malaspina A, Paredes R, Wilson C, Nowak P, Klatt N, Lagenaur L, Landay A. “A Summary of the Third Annual HIV Microbiome Workshop“. AIDS Res Hum Retroviruses. 2018 Oct;34(10):828-834. PMID: 30105916.
Vadrevu SK, Trbojevic-Akmacic I, Kossenkov AV, Colomb F, Giron LB, Anzurez A, Lynn K, Mounzer K, Landay AL, Kaplan RC, Papasavvas E, Montaner LJ, Lauc G, Abdel-Mohsen M. “Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy“. J Leukoc Biol. 2018 Sep;104(3):461-471. PMCID: PMC6113120.
Massanella M, Yek C, Lada SM, Nakazawa M, Shefa N, Huang K, Richman DD. “Improved assays to measure and characterize the inducible HIV reservoir“. EBioMedicine. 2018 Oct;36:113-121.
Xu Z, Wise MC, Choi H, Perales-Puchalt A, Patel A, Tello-Ruiz E, Chu JD, Muthumani K, Weiner DB. “Synethic DNA delivery by electroporation promotes robust in vivo sulfation of broadly neutralizing anti-HIV immunoadhesin eCD4-Ig“. EBioMedicine. 2018 Sep; 35:97-105. PMID:30174283.
Clarke EL, Connell AJ, Six E, Kadry NA, Abbas AA, Hwang Y, Everett JK, Hofstaedter CE, Marsh R, Armant M, Kelsen J, Notarangelo LD, Collman RG, Hacein-Bey-Abina S, Kohn DB, Cavazzana M, Fischer A, Williams DA, Pai SY, Bushman FD. “T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency“. Genome Med. 2018 Sep 28;10(1):70. PMCID: PMC6161392.
Veenhuis RT, Kwaa AK, Garliss CC, Latanich R, Salgado M, Pohlmeyer CW, Nobles CL, Gregg J, Scully EP, Bailey JR, Bushman FD, Blankson JN. “Long-term remission despite clonal expansion of replication-competent HIV-1 isolates“. JCI Insight. 2018 Sep 20;3(18). pii: 122795. [Epub ahead of print] PMID: 30232278.
Mendoza P, Gruell H, Nogueira L, Pai JA, Butler AL, Millard K, Lehmann C, Suárez I, Oliveira TY, Lorenzi JCC, Cohen YZ, Wyen C, Kümmerle T, Karagounis T, Lu CL, Handl L, Unson-O’Brien C, Patel R, Ruping C, Schlotz M, Witmer-Pack M, Shimeliovich I, Kremer G, Thomas E, Seaton KE, Horowitz J, West AP Jr, Bjorkman PJ, Tomaras GD, Gulick RM, Pfeifer N, Fätkenheuer G, Seaman MS, Klein F, Caskey M, Nussenzweig MC. “Combination therapy with anti-HIV-1 antibodies maintains viral suppression“. Nature. 2018 Sep;561(7724):479-484. PMCID: PMC6166473.
Bertagnolli LN, White JA, Simonetti FR, Beg SA, Lai J, Tomescu C, Murray AJ, Antar AAR, Zhang H, Margolick JB, Hoh R, Deeks SG, Tebas P, Montaner LJ, Siliciano RF, Laird GM, Siliciano JD.” The role of CD32 during HIV-1 infection“. Nature. 2018 Sep;561(7723):E17-E19. PMID: 30232425.
Cohen YZ, Lorenzi JCC, Krassnig L, Barton JP, Burke L, Pai J, Lu CL, Mendoza P, Oliveira TY, Sleckman C, Millard K, Butler AL, Dizon JP, Belblidia SA, Witmer-Pack M, Shimeliovich I, Gulick RM, Seaman MS, Jankovic M, Caskey M, Nussenzweig MC. “Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117“. J Exp Med. 2018 Sep 3;215(9):2311-2324. PMCID: PMC6122972.
Ecker C, Riley JL. “Translating In Vitro T Cell Metabolic Findings to In Vivo Tumor Models of Nutrient Competition“. Cell Metab. 2018 Aug 7;28(2):190-195. PMID: 30089240.
Tso FY, Kang G, Kwon EH, Julius P, Li Q, West JT, Wood C. “Brain is a potential sanctuary for subtype C HIV-1 irrespective of ART treatment outcome“. PLoS One. 2018 Jul 24;13(7):e0201325. PMCID: PMC6057662.
Cohen YZ, Caskey M. “Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection. Curr Opin HIV AIDS“. 2018 Jul;13(4):366-373. PMID: 29697469.
Salantes DB, Zheng Y, Mampe F, Srivastava T, Beg S, Lai J, Li JZ, Tressler RL, Koup RA, Hoxie J, Abdel-Mohsen M, Sherrill-Mix S, McCormick K, Overton ET, Bushman FD, Learn GH, Siliciano RF, Siliciano JM, Tebas P, Bar KJ. “HIV-1 latent reservoir size and diversity are stable following brief treatment interruption“. J Clin Invest. 2018 Jul 2;128(7):3102-3115. PMID: 29911997.
Papasavvas E, Lada SM, Joseph J, Yin X, Liu Q, Azzoni L, Mounzer K, Kostman JR, Richman D, Montaner LJ. “Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV“. AIDS. 2018 Jun 11. PMCID: PMC6289896.
Szaniawski MA, Spivak AM, Cox JE, Catrow JL, Hanley T, Williams ESCP, Tremblay MJ, Bosque A, Planelles V. “SAMHD1 Phosphorylation Coordinates the Anti-HIV-1 Response by Diverse Interferons and Tyrosine Kinase Inhibition“. MBio. 2018 May 15;9(3). pii: e00819-18. PMCID: PMC5954222.
Sengupta S, Siliciano RF. “Targeting the Latent Reservoir for HIV-1“. Immunity. 2018 May 15;48(5):872-895. Review. PMCID: PMC6196732.
Cohn LB, da Silva IT, Valieris R, Huang AS, Lorenzi JCC, Cohen YZ, Pai JA, Butler AL, Caskey M, Jankovic M, Nussenzweig MC. “Clonal CD4(+) T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation“. Nat Med. 2018 May;24(5):604-609. PMCID: PMC5972543.
Abdel-Mohsen M, Kuri-Cervantes L, Grau-Exposito J, Spivak AM, Nell RA, Tomescu C, Vadrevu SK, Giron LB, Serra-Peinado C, Genescà M, Castellví J, Wu G, Del Rio Estrada PM, González-Navarro M, Lynn K, King CT, Vemula S, Cox K, Wan Y, Li Q, Mounzer K, Kostman J, Frank I, Paiardini M, Hazuda D, Reyes-Terán G, Richman D, Howell B, Tebas P, Martinez-Picado J, Planelles V, Buzon MJ, Betts MR, Montaner LJ. “CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells“. Sci Transl Med. 2018 Apr 18;10(437). pii: eaar6759. PMCID: PMC6282755.
Szaniawski, M.A., Spivak, A.M., Cox, J.E., Catrow, J.L., Hanley, T., Williams, ESCP., Tremblay, M.J., Bosque, A., Planelles, V. “SAMHD1 Phosphorylation Coordinates the Anti-HIV-1 Response by Diverse Interferons and Tyrosine Kinase Inhibition.” MBio. 2018 May 15;9(3). pii: e00819-18. doi: 10.1128/mBio.00819-18.
Ecker C, Guo L, Voicu S, Gil-de-Gomez L, Medvec A, Cortina L, Pajda J, Andolina M, Torres-Castillo M, Donato JL, Mansour S, Zynda ER, Lin PY, Varela-Rohena A, Blair IA, Riley JL. “Differential Reliance on Lipid Metabolism as a Salvage Pathway Underlies Functional Differences of T Cell Subsets in Poor Nutrient Environments.” Cell Rep. 2018 Apr 17;23(3):741-755. doi: 10.1016/j.celrep.2018.03.084.
Vadrevu SK, Trbojevic-Akmacic I, Kossenkov AV, Colomb F, Giron LB, Anzurez A, Lynn K, Mounzer K, Landay AL, Kaplan RC, Papasavvas E, Montaner LJ, Lauc G, Abdel-Mohsen M. “Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy.” J Leukoc Biol. 2018 Apr 6. doi: 10.1002/JLB.3HI1217-500R. [Epub ahead of print]
Cohen YZ, Lorenzi JCC, Seaman MS, Nogueira L, Schoofs T, Krassnig L, Butler A, Millard K, Fitzsimons T, Daniell X, Dizon JP, Shimeliovich I, Montefiori DC, Caskey M, Nussenzweig MC. “Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells.” J Virol. 2018 Feb 12;92(5). pii: e01883-17. doi: 10.1128/JVI.01883-17. Print 2018 Mar 1.
Cummins NW, Rizza S, Litzow MR, Hua S, Lee GQ, Einkauf K, Chun TW, Rhame F, Baker JV, Busch MP, Chomont N, Dean PG, Fromentin R, Haase AT, Hampton D, Keating SM, Lada SM, Lee TH, Natesampillai S, Richman DD, Schacker TW, Wietgrefe S, Yu XG, Yao JD, Zeuli J, Lichterfeld M, Badley AD. “Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.” PLoS Med. 2017 Nov 28;14(11):e1002461. doi: 10.1371/journal.pmed.1002461. eCollection 2017 Nov.
Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, Metcalf-Pate K, Hobbs KS, Thanh C, Gibson EA, Kuritzkes DR, Siliciano RF, Price RW, Richman DD, Chomont N, Siliciano JD, Mellors JW, Yukl SA, Blankson JN, Liegler T, Deeks SG. “HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.” PLoS Med. 2017 Nov 7;14(11):e1002417. doi: 10.1371/journal.pmed.1002417. eCollection 2017 Nov.
Spivak AM, Planelles V. “Novel Latency Reversal Agents for HIV-1 Cure.” Annu Rev Med. 2017 Nov 3. [Epub ahead of print.]
Leibman RS, Richardson MW, Ellebrecht CT, Maldini CR, Glover JA, Secreto AJ, et al. “Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor.” PLoS Pathog. 2017;13(10): e1006613.
Mikulak J, Oriolo F, Zaghi E, Di Vito C, Mavilio D.” Natural Killer Cells in HIV-1 Infection and Therapy.” AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001645.
Kurachi M, Kurachi J, Chen Z, Johnson J, Khan O, Bengsch B, Stelekati E, Attanasio J, McLane LM, Tomura M, Ueha S, Wherry EJ. “Optimized retroviral transduction of mouse T cells for in vivo assessment of gene function.” Nat Protoc. 2017 Sep;12(9):1980-1998. doi: 10.1038/nprot.2017.083. Epub 2017 Aug 31.
Yek C, Massanella M, Peling T, Lednovich K, Nair SV, Worlock A, Vargas M, Gianella S, Ellis RJ, Strain MC, Busch MP, Nugent T, Richman DC. “Evaluation of the Aptima HIV-1 Quant Dx Assay for HIV-1 RNA Quantitation in Different Biological Specimen Types.” J Clin Microbiol. 2017 August;55(8):2544-2553. doi: 10.1128/JCM.00425-17.
Honeycutt JB, Thayer WO, Baker CE, Ribeiro RM, Lada SM, Cao Y, Cleary RA, Hudgens MG, Richman DD, Garcia JV. “HIV Persistence in tissue macrophages of humanized mice during ART.” Nat Med. 2017 May;23(5):638-643. doi: 10.1038/nm.4319.
Pollack RA, Jones RB, Pertea M, Bruner KM, Martin AR, Thomas AS, Capoferri AA, Beg SA, Huang SH, Karandish S, Hao H, Halper-Stromberg E, Yong PC, Kovacs C, Benko E, Siliciano RF, Ho YC. “Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape.“Cell Host Microbe. 2017 Apr 12;21(4):494-506.e4. doi: 10.1016/j.chom.2017.03.008.
Hosmane NN, Kwon KJ, Bruner KM, Capoferri AA, Beg S, Rosenbloom DI, Keele BF, Ho YC, Siliciano JD, Siliciano RF. “Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics.” J Exp Med. 2017 Mar 24. pii: jem.20170193. doi: 10.1084/jem.20170193.
Mikulak J, Di Vito C, Zaghi E, Mavilio D. “Host Immune Responses in HIV-1 Infection: The Emerging Pathogenic Role of Siglecs and Their Clinical Correlates.” Front Immunol. 2017 Mar 23;8:314. doi: 10.3389/fimmu.2017.00314.
Riley JL, Montaner LJ. “Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir.” J Infect Dis. 2017 Mar 15;215(suppl_3):S160-S171. doi: 10.1093/infdis/jix002.
Martin AR, Pollack RA, Capoferri A, Ambinder RF, Durand CM, Siliciano RF. “Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity.” J Clin Invest. 2017 Feb 1;127(2):651-656. doi: 10.1172/JCI89552. PMID: 28094770
Tomescu C, Tebas P, Montaner. “IFN-α Augments NK-mediated Antibody-Dependent Cellular Cytotoxicity (ADCC) of HIV-1 Infected Autologous CD4+ T Cells Regardless of MHC-I Downregulation.” AIDS. 2017 Jan. DOI: 10.1097/QAD.0000000000001380
Caskey M, Schoofs T, Gruell H, Settler A, Karagounis T, Kreider EF, Murrell B, Pfeifer N, Nogueira L, Oliveira TY, Learn GH, Cohen YZ, Lehmann C, Gillor D, Shimeliovich I, Unson-O’Brien C, Weiland D, Robles A, Kümmerle T, Wyen C, Levin R, Witmer-Pack M, Eren K, Ignacio C, Kiss S, West AP Jr, Mouquet H, Zingman BS, Gulick RM, Keler T, Bjorkman PJ, Seaman MS, Hahn BH, Fätkenheuer G, Schlesinger SJ, Nussenzweig MC, Klein F. “Antibody 10-1074 suppresses viremia in HIV-1 infected individuals.” Nat Med. 2017 Jan 16. doi: 10.1038/nm.4268. [Epub ahead of print] PMID: 28092665 [PubMed – as supplied by publisher]
Iyer SS, Bibollet-Ruche F, Sherrill-Mix S, Learn GH, Plenderleith L, Smith AG, Barbian HJ, Russell RM, Gondim MV, Bahari CY, Shaw CM, Li Y, Decker T, Haynes BF, Shaw GM, Sharp PM, Borrow P, Hahn BH. “Resistance to type I interferons is a major determinant of HIV-1 transmission fitness.” Proc Natl Acad Sci U S A. 2017 Jan 24;114(4): E590-E599. doi: 10.1073/pnas.1620144114. PMID: 28069935 [PubMed – in process]
Yuan Z, Kang G, Lu W, and Li Q. “Reactivation of HIV-1 proviruses in immune-compromised mice engrafted with human VOA-negative CD4+ T Cells.” J Virus Eradication. 2017; 3: 61-65.
Lorenzi JC, Cohen YZ, Cohn LB, Kreider EF, Barton JP, Learn GH, Oliveira T, Lavine CL, Horwitz JA, Settler A, Jankovic M, Seaman MS, Chakraborty AK, Hahn BH, Caskey M, Nussenzweig MC. “Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.” Proc Natl Acad Sci U S A. 2016 Dec 6;113(49): E7908-E7916. Erratum in: Proc Natl Acad Sci U S A. 2017 Jan 17. PMID: 27872306 [PubMed – in process]
Bar KJ, Sneller MC, Harrison LJ, Justement JS, Overton ET, Petrone ME, Salantes DB, Seamon CA, Scheinfeld B, Kwan RW, Learn GH, Proschan MA, Kreider EF, Blazkova J, Bardsley M, Refsland EW, Messer M, Clarridge KE, Tustin NB, Madden PJ, Oden K, O’Dell SJ, Jarocki B, Shiakolas AR, Tressler RL, Doria-Rose NA, Bailer RT, Ledgerwood JE, Capparelli EV, Lynch RM, Graham BS, Moir S, Koup RA, Mascola JR, Hoxie JA, Fauci AS, Tebas P, Chun TW. “Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption.” N Engl J Med. 2016 Nov 24;375(21):2037-2050. PMID: 27959728 [PubMed – indexed for MEDLINE]